The Nebraska Medical Association

https://www.nebmed.org/

 

Nebraska Oncology Society
G

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III Trials? How Effective Is Lurbinectedin in Stage IV Disease Progressed After 1L Therapy?

By Nebraska Oncology Society FEATURING Gregory Riely
By Nebraska Oncology Society FEATURING Gregory Riely
93 views
October 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Nebraska Oncology Society
07:33

Targeted Therapy for mNSCLC: What Is the Response Rate With Selperca…

Nebraska Oncology Society

G. Riely

199 views
15:24

NSCLC Targeted Therapies Update: Should We Consider EGFR Targeted Th…

Nebraska Oncology Society

G. Riely

159 views
09:41

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS …

Nebraska Oncology Society

E. Sherman

13 views
09:24

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDD…

Nebraska Oncology Society

E. Sherman

13 views
11:38

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Le…

Nebraska Oncology Society

E. Sherman

20 views
04:56

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

15 views
08:09

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

25 views
06:13

Nebraska Oncology Society 2020 Update on Advanced UC: Is Atezo Benef…

Nebraska Oncology Society

N. Vogelzang

48 views
17:42

Nebraska Oncology Society 2020 Update on PC: Does 18F-DCFPyL-PET/CT …

Nebraska Oncology Society

N. Vogelzang

118 views
13:26

Nebraska Oncology Society 2020 Update on Advanced RCC: Is 1L Pembro+…

Nebraska Oncology Society

N. Vogelzang

170 views
11:59

2020 ASCO mCRC Updates Recap: Did We Experience Pseudoprogression Wi…

Nebraska Oncology Society

G. Kim

48 views
05:11

2020 ASCO Updates on GI Cancers: Is Chemo w/ mFOLFIRINOX More Effect…

Nebraska Oncology Society

G. Kim

13 views
10:06

2020 ASCO Highlights on Advanced CRC: Does mFOLFIRINOX Show DFS Bene…

Nebraska Oncology Society

G. Kim

15 views
04:13

2020 ASCO Updates on mCRC: Is Adjuvant mFOLFOX Superior to Hepatecto…

Nebraska Oncology Society

G. Kim

25 views
07:52

2020 ASCO Highlights on Stage 3 Colon Cancer: What Are the DFS/OS Di…

Nebraska Oncology Society

G. Kim

21 views
10:48

KEYNOTE-177 2020 ASCO Update on MSI-H/dMMR mCRC: Does Pembro Improve…

Nebraska Oncology Society

G. Kim

28 views
07:39

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III T…

Nebraska Oncology Society

G. Riely

93 views
16:08

Stage IV NSCLC 2020 Update: Is There a Benefit to Short-Course Chemo…

Nebraska Oncology Society

G. Riely

122 views
30:39

2020 ASCO Updates on IO in Advanced Melanoma: What Are the Outcomes …

Nebraska Oncology Society

S. Bhatia

65 views
10:23

2020 ASCO Highlights on Neoadjuvant IO in Stage 3 Melanoma: Does Ipi…

Nebraska Oncology Society

S. Bhatia

43 views
21:02

2020 ASCO Updates on Frontline Multiple Myeloma: KRd vs. VRd - What …

Nebraska Oncology Society

A. Cohen

302 views
25:01

2020 ASCO Updates on R/R Myeloma: Does FDA-Approved Selinexor Offer …

Nebraska Oncology Society

A. Cohen

335 views